Ostéoporose [Osteoporosis]

Détails

Ressource 1Télécharger: 56-8_42870.pdf (114.30 [Ko])
Etat: Public
Version: Final published version
Licence: Non spécifiée
ID Serval
serval:BIB_1352CDA98BB8
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Ostéoporose [Osteoporosis]
Périodique
Revue medicale suisse
Auteur⸱e⸱s
Gonzalez Rodriguez E., Debrach-Schneider A.C., Lamy O.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Statut éditorial
Publié
Date de publication
19/01/2022
Peer-reviewed
Oui
Volume
18
Numéro
764-5
Pages
56-58
Langue
français
Notes
Publication types: Journal Article ; Review
Publication Status: ppublish
Résumé
The year 2021 is marked by several articles aimed at better risk stratification of osteoporosis to define the groups of patients at very high risk of fractures or at imminent risk of fractures. This stratification determines who should benefit from a first line bone anabolic treatment. A review of the current state of osteoporosis was therefore essential; it shows that Switzerland is lagging. In terms of prevention of bone fragility, dairy products are probably a leading strategy, especially in the elderly. The practical management of denosumab discontinuation is finally better understood. Finally, with the arrival of a new treatment, Burosumab, we are experiencing a therapeutic revolution for rare hypophosphatemic diseases.
Mots-clé
Aged, Bone Density, Bone Density Conservation Agents/therapeutic use, Denosumab/therapeutic use, Humans, Osteoporosis/drug therapy, Osteoporosis/epidemiology, Osteoporosis, Postmenopausal, Osteoporotic Fractures/epidemiology, Osteoporotic Fractures/prevention & control, Switzerland
Pubmed
Création de la notice
31/01/2022 12:56
Dernière modification de la notice
05/02/2022 8:08
Données d'usage